{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "inhibits_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P42224",
      "entity_text" : "STAT1",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05236",
      "entity_text" : "JEV NS5",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "We first demonstrated that JEV NS5 expression in human medulloblastoma cells inhibits (a) IFNbeta induced ISRE promoter activities, (b) IFNbeta stimulated gene expression, and (c) suppression of IFNbeta induced nuclear translocation and phosphorylation of STAT1.",
  "reading_complete" : "2020-08-08T14:52:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:48:29Z",
  "trigger" : "induced",
  "evidence" : [ "JEV NS5 expression in human medulloblastoma cells inhibits (a) IFNbeta-induced ISRE promoter activities, (b) IFNbeta-stimulated gene expression, and (c) suppression of IFNbeta-induced nuclear translocation and phosphorylation of STAT1" ],
  "pmc_id" : "7167617",
  "score" : 0
}